The work of Thale Olsen and Jörg Otte has been awarded funding from the Swedish Research Council.

The Baryawno research group has been awarded a 4-year funding of 4,8 million SEK from the Swedish Research Council (Vetenskapsrådet, VR) for the work on the “Functional characterization and targeting of the neuroblastoma stem cell”. This work is based on the manuscript that Thale Olsen and Jörg Otte has been working on for 4 years in collaboration with the Kharchenko lab at Harvard Medical School.